Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What disciplinary measures might be imposed if my pharmacy is referred to the disciplinary committee of the Pharmacy and Poisons Board (PPB) for a breach?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q408 · Category I: Renewals, changes and penalties for non-compliance (Q401–Q450)
If your pharmacy is referred to the PPB’s Disciplinary Committee on suspicion of breaching the Pharmacy and Poisons Ordinance or a relevant code of practice, the Committee may impose various sanctions after completing a hearing and finding the allegations substantiated. These sanctions include issuing a written warning to the licence holder; ordering the licence holder to rectify the breach within a specified period; ordering suspension of the licence for a period, such as 14 days or longer; and, in the most serious cases, ordering revocation of your licence. The Disciplinary Committee may also order the licence holder to pay the costs relating to the disciplinary proceedings.

📘 Regulatory basis

Section 9 of the Pharmacy and Poisons Ordinance (Cap. 138) confers disciplinary powers on the Pharmacy and Poisons Board.

📗 Drew Tang's recommendations

If you receive notice of a disciplinary hearing, do not take it lightly. You should immediately seek professional legal and compliance advice. Rengangyongsheng (Hong Kong) Limited can help you review the case, prepare your defence materials and simulate the hearing, with a view to minimising potential penalties.

📕 Risk notice

Disciplinary decisions are generally published in the Government Gazette, making your breach a matter of public record and seriously damaging the company’s reputation and business standing. Suspension or revocation of a licence directly disrupts business operations.

Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗